206 related articles for article (PubMed ID: 29845285)
1. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
[TBL] [Abstract][Full Text] [Related]
3. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
Lin Z; Xiong L; Lin Q
Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
[TBL] [Abstract][Full Text] [Related]
5. RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway.
Xie G; Wu H; Cai W; Chen M; Huang W; Yan W; Chang Y
FEBS Open Bio; 2019 Mar; 9(3):490-497. PubMed ID: 30868057
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.
Cheng H; Zhang Z; Borczuk A; Powell CA; Balajee AS; Lieberman HB; Halmos B
Carcinogenesis; 2013 Apr; 34(4):739-49. PubMed ID: 23275151
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L.
Chen X; Zhu H; Ye W; Cui Y; Chen M
Mol Med Rep; 2019 Feb; 19(2):831-840. PubMed ID: 30535450
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.
Dukaew N; Konishi T; Chairatvit K; Autsavapromporn N; Soonthornchareonnon N; Wongnoppavich A
Oncol Res; 2020 Mar; 28(2):161-175. PubMed ID: 31727206
[TBL] [Abstract][Full Text] [Related]
9. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer.
Gou W; Yu X; Wu S; Wu H; Chang H; Chen L; Wei H; Bi C; Ning H; Wu Y; Hou W; Zuo D; Li Y
Cancer Lett; 2022 Apr; 530():100-109. PubMed ID: 35065237
[TBL] [Abstract][Full Text] [Related]
11. Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin.
Wan Q; Shen Y; Zhao H; Wang B; Zhao L; Zhang Y; Bu X; Wan M; Shen C
J Cell Physiol; 2019 Jul; 234(7):10360-10371. PubMed ID: 30417376
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
[TBL] [Abstract][Full Text] [Related]
13. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines.
Sak A; Groneberg M; Stuschke M
Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365
[No Abstract] [Full Text] [Related]
14. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
[TBL] [Abstract][Full Text] [Related]
15. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
[TBL] [Abstract][Full Text] [Related]
16. RDM1 promotes critical processes in breast cancer tumorigenesis.
Chen Y; Sun Z; Zhong T
J Cell Mol Med; 2019 Aug; 23(8):5432-5439. PubMed ID: 31222930
[TBL] [Abstract][Full Text] [Related]
17. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
18. NME4 may enhance non‑small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation.
Wang W; Dong M; Cui J; Xu F; Yan C; Ma C; Yi L; Tang W; Dong J; Wei Y
Mol Med Rep; 2019 Aug; 20(2):1629-1636. PubMed ID: 31257488
[TBL] [Abstract][Full Text] [Related]
19. Association of RDM1 with osteosarcoma progression via cell cycle and MEK/ERK signalling pathway regulation.
Sheng J; Liu K; Sun D; Nie P; Mu Z; Chen H; Zhang Z
J Cell Mol Med; 2021 Aug; 25(16):8039-8046. PubMed ID: 34264012
[TBL] [Abstract][Full Text] [Related]
20. RDM1 plays an oncogenic role in human lung adenocarcinoma cells.
Tong L; Liu J; Yan W; Cao W; Shen S; Li K; Li L; Niu G
Sci Rep; 2018 Aug; 8(1):11525. PubMed ID: 30069034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
